posted
eFoodSafety.com, Inc.'s Cinnergen Diabetes Product Available for Sale at Major Internet Retailer, Drugstore.com Patricia Gruden, President/CEO of eFoodSafety.com, Inc. (OTCBB:EFSF) announced today that Cinnergen(TM), an all natural liquid nutritional supplement designed to regulate blood sugar, is now available for purchase from Drugstore.com (NASD: DSCM) (http://www.drugstore.com).
As a result of our continued Direct Response Marketing Campaign via radio and TV, Drugstore.com, with a total life-to-date customer base of approximately 6.8 million unique customers since inception, has expressed the desire to sell our product. Cinnergen(TM) is a fitting addition to the drugstore.com online store as they currently provide a convenient, private, and informative shopping experience that encourages consumers to buy products essential to healthy everyday living.
Cinnergen(TM) is a patent pending nutritional supplement with 0 calories, 0 grams of fat, 0 carbohydrates, and 0 grams of sugar. Cinnergen(TM) delivers concentrated nutrition to help the body efficiently and effectively metabolize sugar. As the body becomes more efficient with glucose metabolism, overall health is improved.
Drugstore.com, Inc. is a leading online provider of health, beauty, vision and pharmacy solutions through their website www.drugstore.com. Drugstore.com, Inc. has three (3) wholly-owned subsidiaries - Beauty.com, Custom Nutrition Services, Inc., and International Vision Direct Corp. Drugstore.com is partners with Amazon.com (NasdaqNM: AMZN), CIGNA HealthCare Companies (NYSE: CI), General Nutrition Companies, Inc., MSN (NasdaqNM: MSFT), PetCareRX, Rite-Aid Corporation (NYSE: RAD), to name a few.
"Feedback from our customers has been overwhelmingly positive and Cinnergen(TM) sales continue to escalate rapidly. With Drugstore.com making Cinnergen(TM) readily available, more consumers will be provided the opportunity to purchase Cinnergen(TM) and improve the quality of their life and health," stated Patricia Ross-Gruden, President and CEO of eFoodSafety.com, Inc.
About Cinnergen(TM)
Cinnergen(TM) (www.cinnergen.com) is a once-a-day formula made from 15 whole foods that contain no fats, carbohydrates, sugar, or calories. Cinnergen(TM) is specially formulated to promote healthy glucose metabolism and to decrease the symptoms that commonly accompany elevated blood sugar and its effects. Cinnergen(TM) delivers concentrated nutrition to help the body efficiently and effectively metabolize sugar. As a whole food complex, Cinnergen(TM) provides several key ingredients that have been proven clinically through years of research to improve digestion and utilization of sugar, which are generally deficient in a typical American diet.
About eFoodSafety.com, Inc.
eFoodSafety.com, Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also is a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and most recently became a distributor for Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes.
Safe Harbor Forward-Looking Statements
Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements invoke risk and uncertainties and the company's actual results may differ from these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.